Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 10, 2014 19:48 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Oct. 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on September 26, 2014, the Compensation Committee of the Company's Board...
August 11, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Submits New Drug Submission to Health Canada for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat

WESTLAKE VILLAGE, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it submitted a New Drug Submission (NDS) to Health Canada seeking approval...
August 07, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Releases Second Quarter 2014 Operating Results

WESTLAKE VILLAGE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc.(Nasdaq:KYTH) today reported financial results for its second quarter 2014 and provided an update on recent...
July 31, 2014 16:17 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release Second Quarter 2014 Operating Results

WESTLAKE VILLAGE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its second quarter 2014 operating results and will host an...
July 10, 2014 16:32 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces FDA Acceptance of ATX-101 New Drug Application

CALABASAS, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid), has been...
June 06, 2014 17:21 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at the Goldman Sachs 35th Annual Global Healthcare Conference

CALABASAS, Calif., June 6, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the...
May 12, 2014 19:30 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Submits New Drug Application for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat

CALABASAS, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug...
May 08, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Releases First Quarter 2014 Operating Results

CALABASAS, Calif., May 8, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2014, and provided an update on recent...
May 07, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

CALABASAS, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of...
April 24, 2014 17:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release First Quarter 2014 Operating Results

CALABASAS, Calif., April 24, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its first quarter 2014 operating results and will host an investor...